Northwire Canada EditionMonday, July 13, 2026
Northwire
S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.280 +0.0% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4% S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.280 +0.0% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4%
Earnings

Eshbal Announces Upcoming Webinar

ESBL · Price

Executive Summary

  • Eshbal Functional Food Inc. will host a public webinar on Dec 11, 2025 to present its record Q3 2025 quarterly financials and discuss the recently signed definitive agreement to acquire Dare To Be Different Foods (D2BD).
  • The webinar marks the company’s first open‑public presentation, providing investors an opportunity for a live Q&A on the firm’s North‑American expansion strategy.
  • Management will outline organic growth initiatives, further M&A opportunities and the company’s outlook for continued revenue expansion in the gluten‑free “better‑for‑you” market.

Key Details

  • Webinar Date & Time: Dec 11, 2025 at 12:00 PM Eastern Time (US & Canada).
  • Registration Link: https://us02web.zoom.us/webinar/register/WN_FJkR_owXTCezNUYW3fe72Q
  • Topic: “Eshbal Functional Food Inc. Q3/25 Webinar.”
  • Management Participants: CEO Tomer Bar Meir, Head of Investor Communications Anat Shuhami, and other senior executives.
  • Financial Highlights to be Discussed: Record quarterly results for Q3 2025 (specific figures to be disclosed during the call).
  • Acquisition Update: Definitive agreement signed with NYC‑based Dare To Be Different Foods (D2BD); details of transaction terms will be presented.
  • Strategic Focus: Expansion into U.S. market, strengthening commercial infrastructure, evaluating additional M&A targets, and scaling organic growth in the gluten‑free/health‑focused food segment.
  • Company Background (boilerplate removed for brevity): Over 300 SKUs, > US$11 M revenue in 2024, active consolidation strategy in artisanal gluten‑free market.

Notable Quotes

  • “We are excited to open a direct channel with the market and provide transparency on our strong Q3 performance and strategic acquisition,” – Tomer Bar Meir, CEO.
Read the original news release →

More from Eshbal Functional Food Inc.